Table 2.
Characteristic | Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|---|
HR (95% CI) | P-value* | HR (95%CI) | P-value* | ||
Age (years) | Continuous | 0.296 | |||
Smoking Status | Smoker | 1 | |||
Never | 2.3(0.96–5.9) | 0.061 | |||
Gender | Male | 1 | |||
Female | 0.25(0.01–1.5) | 0.142 | |||
Subsite | Tonsil | 1 | |||
Base of Tongue | 1.2(0.48–3.18) | 0.667 | |||
HPV/P16 Status | Positive | 1 | |||
Negative | 1.1(0.05–12) | 0.935 | |||
T Stage | 0–2 | 1 | 1 | ||
3–4 | 3.8(2.25–15.7) | 0.0002** | 4.56(1.46–15.31) | 0.0089** | |
Nodal Stage | Nx-1 | 1 | |||
N2–3 | 1.88(0.61–7) | 0.286 | |||
Treatment Modalities | |||||
CCRT Only | 1 | 0.0006** | 1 | 0.004** | |
IC+CCRT | 5.6(2.6–16.46) | 6.12(2.01–20.44) | |||
Radiotherapy alone | 0.48(0.07–2.04) | 0.72(0.06–4.82) | |||
Radiotherapy Technique | Split | 1 | |||
Whole Field | 1.0(0.67–4) | 0.286 | |||
Total Radiotherapy Dose | Continuous | 0.041** | 0.696 | ||
Number of Radiotherapy Fractions | Continuous | 0.053 | |||
Baseline RAD, Per | No (Score 0) | 1 | 0.019** | 1 | 0.265 |
DIGEST | |||||
Yes (Score 1-4) | 2.0(1.197-7.36) | 1.84(0.62-5.42) |
P-values were calculated by the Chi-square test.
Statistically significant p-value < 0.05.
Abbreviations: CCRT; concurrent chemo/radiotherapy, IC; induction chemotherapy, RAD; radiation-associated dysphagia, DIGEST; Dynamic Imaging Grade of Swallowing Toxicity.